Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Gross Margin

The Gross Margin of Akebia Therapeutics Inc (AKBA) is 83.67%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

AKBA Gross Margin - Historical Value
Date Value
2024-12-31 83.67%
2023-12-31 79.58%
2022-12-31 92.31%
2021-12-31 51.25%
2020-12-31 55.13%
2019-12-31 66.42%
2018-12-31 96.97%
2017-12-31 100.00%
AKBA Gross Margin - Peers Comparison